We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00266084
First Posted: December 15, 2005
Last Update Posted: May 11, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospitals Cleveland Medical Center
December 14, 2005
December 15, 2005
May 11, 2016
August 1999
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00266084 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix
Double-Blinded Multicenter Clinical Study Assessing the Equivalence of the InPath Cervical Cell Collector to the Standard Endocervical Brush and Spatula in Patients Seeking Primary Pap Screening or Follow-up Screening
This study tested the safety and performance of a new cell collector device and compared the results to those obtained with the current existing device that are being used routinely
This study tested the feasibility, safety and efficacy of the new e2TM Collector, and compared its performance with the standard method for obtaining cervical cells for Pap test of endocervical cytobrush and Ayer's Spatula
Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
  • Uterine Cervical Dysplasia
  • Uterine Cervical Intraepithelial Neoplasia
  • Uterine Cervical Neoplasia
  • Uterine Cervical Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
85
November 2001
Not Provided

Inclusion Criteria:

Women ages >14 being followed for a previous abnormal Pap All patients will have signed an Informed Consent form prior to being enrolled in this study

Exclusion Criteria:

Patients who have had a hysterectomy

Sexes Eligible for Study: Female
14 Years and older   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00266084
02-00-16
Not Provided
Not Provided
Not Provided
Not Provided
University Hospitals Cleveland Medical Center
Not Provided
Principal Investigator: George I Gorodeski, MD PhD University Hospitals of Cleveland, Case Western Reserve University
University Hospitals Cleveland Medical Center
November 2001